TickerLeague

Revenue for Viatris (VTRS)

According to Viatris's latest reported financial statements, the company's current revenue (TTM) is $14.30B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$14.30B

YoY change

-3.0%

5Y CAGR

+3.7%

Peak year (2021)

$17.89B

Cumulative revenue

$195.94B

Revenue history chart for Viatris (VTRS) from 2003 to 2025

Revenue history table for Viatris (VTRS) from 2003 to 2025

Fiscal yearPeriod endedReportedRevenueYoY
2025$14.30B-3.0%
2024$14.74B-4.5%
2023$15.43B-5.1%
2022$16.26B-9.1%
2021$17.89B+49.7%
2020$11.95B+3.9%
2019$11.50B+0.6%
2018$11.43B-4.0%
2017$11.91B+7.5%
2016$11.08B+17.5%
2015$9.43B+22.1%
2014$7.72B+11.7%
2013$6.91B+1.7%
2012$6.80B+10.9%
2011$6.13B+12.5%
2010$5.45B+7.0%
2009$5.09B-0.9%
2008$5.14B+76.9%
2007$2.91B
2005$1.26B+0.3%
2004$1.25B-8.8%
2003$1.37B

Revenue values are taken from Viatris's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual revenue for Viatris (VTRS) came in at $14.30B – edged down 3.0% year-over-year.

Viatris revenue compound annual growth for the 2020–2025 (5 years) window is +3.7%, with the latest reading among the more recent periods of the dataset.

Between 2021 and 2025, Viatris revenue declined 20.1%, falling from $17.89B to $14.30B.

The dataset's maximum revenue sits at $17.89B (2021); the minimum reading of $1.25B dates to 2004.

Among 8 Healthcare peers, Viatris (VTRS) ranks 9th; the peer median for revenue is $65.09B.

Viatris Revenue by Year

Viatris Revenue 2025: $14.30B

Viatris revenue in 2025 was $14.30B, edged down 3.0% below 2024.

Viatris Revenue 2024: $14.74B

Viatris revenue in 2024 was $14.74B, edged down 4.5% below 2023.

Viatris Revenue 2023: $15.43B

Viatris revenue in 2023 was $15.43B, declined 5.1% below 2022.

Viatris Revenue 2022: $16.26B

Viatris revenue in 2022 was $16.26B, declined 9.1% below 2021.

Viatris Revenue 2021: $17.89B

Viatris revenue in 2021 was $17.89B.

See more financial history for Viatris (VTRS).

Sector peers — Revenue

Companies in the same sector as Viatris, ranked by their latest revenue.

CompanyRevenueSector
UnitedHealth Group Incorporated (UNH)$447.57BHealthcare
Novo Nordisk A/S (NVO)$309.06BHealthcare
Johnson & Johnson (JNJ)$94.19BHealthcare
Eli Lilly and Company (LLY)$65.18BHealthcare
Merck & Co., Inc. (MRK)$65.01BHealthcare
AbbVie Inc. (ABBV)$61.16BHealthcare
AstraZeneca PLC (AZN)$58.74BHealthcare
Amgen Inc. (AMGN)$36.74BHealthcare

Frequently asked questions

What is Viatris's revenue?

Latest reported revenue for Viatris (VTRS) is $14.30B (period ending December 31, 2025).

How has Viatris revenue changed year-over-year?

Viatris (VTRS) revenue changed -3.0% year-over-year on the latest annual filing.

What is the long-term growth rate of Viatris revenue?

Viatris (VTRS) revenue compound annual growth rate is +3.7% over the most recent 5 years available.

When did Viatris revenue hit its highest annual value?

Viatris revenue reached its highest annual value of $17.89B in 2021.

What was Viatris revenue in 2024?

Viatris (VTRS) revenue in 2024 was $14.74B.

What was Viatris revenue in 2025?

Viatris (VTRS) revenue in 2025 was $14.30B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.